527
Views
38
CrossRef citations to date
0
Altmetric
Review

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption

, &
Pages 67-82 | Published online: 11 Feb 2019

References

  • KönigJWellsJCaniPDHuman intestinal barrier function in health and diseaseClin Transl Gastroenterol2016710e19627763627
  • LechugaSIvanovAIDisruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanismsBiochim Biophys Acta18642017711831194
  • KatoTHondaYKuritaYLubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: a prospective randomized pilot study in healthy volunteersPLoS One2017124e017562628410406
  • CzeruckaDDahanSMograbiBRossiBRampalPSaccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cellsInfect Immun200068105998600410992512
  • OdenwaldMATurnerJRIntestinal permeability defects: is it time to treat?Clin Gastroenterol Hepatol20131191075108323851019
  • GroschwitzKRHoganSPIntestinal barrier function: Molecular regulation and disease pathogenesisJ Allergy Clin Immunol20091241320 quiz 21–2219560575
  • JandhyalaSMTalukdarRSubramanyamCVuyyuruHSasikalaMNageshwar ReddyDRole of the normal gut microbiotaWorld J Gastroenterol201521298787880326269668
  • Rajilić-StojanovićMSmidtHde VosWMDiversity of the human gastrointestinal tract microbiota revisitedEnviron Microbiol2007992125213617686012
  • FreterRBricknerHFeketeJVickermanMMCareyKESurvival and implantation of Escherichia coli in the intestinal tractInfect Immun19833926867036339389
  • KamadaNChenGYInoharaNNúñezGControl of pathogens and pathobionts by the gut microbiotaNat Immunol201314768569023778796
  • UkenaSNSinghADringenbergUProbiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrityPLoS One2007212e130818074031
  • Garcia-GutierrezEMayerMJCotterPDNarbadAGut microbiota as a source of novel antimicrobialsGut Microbes201860121
  • SorgJASonensheinALBile salts and glycine as cogerminants for Clostridium difficile sporesJ Bacteriol200819072505251218245298
  • PengLLiZRGreenRSHolzmanIRLinJButyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayersJ Nutr200913991619162519625695
  • JohanssonMESjövallHHanssonGCThe gastrointestinal mucus system in health and diseaseNat Rev Gastroenterol Hepatol201310635236123478383
  • JohanssonMEVPhillipsonMPeterssonJVelcichAHolmLHanssonGCThe inner of the two MUC2 mucin-dependent mucus layers in colon is devoid of bacteriaProc Natl Acad Sci USA200810539150641506918806221
  • MergaYCampbellBJRhodesJMMucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapyDig Dis201432447548324969297
  • TamuraAHayashiHImasatoMLoss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose malabsorption in mouse small intestineGastroenterology2011140391392320727355
  • LeeSHIntestinal permeability regulation by tight junction: implication on inflammatory bowel diseasesIntest Res2015131111825691839
  • TercioloCDobricAOuaissiMSaccharomyces boulardii CNCM I-745 restores intestinal barrier integrity by regulation of E-cadherin recyclingJ Crohns Colitis2017118999101028333335
  • KimMAshidaHOgawaMYoshikawaYMimuroHSasakawaCBacterial interactions with the host epitheliumCell Host Microbe201081203520638639
  • AwadWHessCHessMPathogensEEnteric pathogens and their toxin-induced disruption of the intestinal barrier through alteration of tight junctions in chickensToxins (Basel)201792E6028208612
  • StierHBischoffSInfluence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune systemClin Exp Gastroenterol2016926927927695355
  • HillDAArtisDIntestinal bacteria and the regulation of immune cell homeostasisAnnu Rev Immunol20102862366720192812
  • LallèsJPIntestinal alkaline phosphatase: novel functions and protective effectsNutr Rev2014722829424506153
  • FörsterCTight junctions and the modulation of barrier function in diseaseHistochem Cell Biol20081301557018415116
  • GuttmanJAFinlayBBTight junctions as targets of infectious agentsBiochim Biophys Acta178820094832841
  • KöhlerHSakaguchiTHurleyBPKaseBAReineckerHCMcCormickBASalmonella enterica serovar Typhimurium regulates intercellular junction proteins and facilitates transepithelial neutrophil and bacterial passageAm J Physiol Gastrointest Liver Physiol20072931G178G18717615177
  • ButsJPDe KeyserNEffects of Saccharomyces boulardii on intestinal mucosaDig Dis Sci20065181485149216838119
  • GraffSChaumeilJCBoyPLai-KuenRCharrueauCInfluence of pH conditions on the viability of Saccharomyces boulardii yeastJ Gen Appl Microbiol200854422122718802321
  • Edwards-IngramLGitshamPBurtonNGenotypic and physiological characterization of Saccharomyces boulardii, the Probiotic strain of Saccharomyces cerevisiaeAppl Environ Microbiol20077382458246717293506
  • FiettoJLAraújoRSValadãoFNMolecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardiiCan J Microbiol200450861562115467787
  • PardoSGalvagnoMACerruttiPStudies of viability and vitality after freezing of the probiotic yeast Saccharomyces boulardii: physiological preconditioning effectRev Iberoam Micol2009262155160 Spanish19631167
  • CarioEBarrier-protective function of intestinal epithelial Toll-like receptor 2Mucosal Immunol2008Suppl 1S62S6619079234
  • YuSGaoNCompartmentalizing intestinal epithelial cell Toll-like receptors for immune surveillanceCell Mol Life Sci201572173343335326001904
  • OppongGORapsinskiGJNewmanTNNishimoriJHBieseckerSGTükelÇEpithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar typhimurium curli fibrils in the gutInfect Immun201381247848623208603
  • SzajewskaHGuarinoAHojsakIEuropean Society for Pediatric Gastroenterology, Hepatology, and NutritionUse of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for probiotics and prebioticsJ Pediatr Gastroenterol Nutr201458453153924614141
  • McFarlandLVSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsWorld J Gastroenterol201016182202222220458757
  • MoréMISwidsinskiASaccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a reviewClin Exp Gastroenterol2015823725526316791
  • BerkesJViswanathanVKSavkovicSDHechtGIntestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammationGut200352343945112584232
  • Ngendahayo MukizaCDubreuilJDEscherichia coli heat-stable toxin B impairs intestinal epithelial barrier function by altering tight junction proteinsInfect Immun20138182819282723716609
  • ShawkiAMcColeDFMechanisms of intestinal epithelial barrier dysfunction by adherent-invasive Escherichia coliCell Mol Gastroenterol Hepatol201731415028174756
  • Ugalde-SilvaPGonzalez-LugoONavarro-GarciaFTight junction disruption induced by type 3 secretion system effectors injected by enteropathogenic and enterohemorrhagic Escherichia coliFront Cell Infect Microbiol201668727606286
  • Shen-TuGKimHLiuMJohnson-HenryKCShermanPMProtein kinase C mediates enterohemorrhagic Escherichia coli O157:H7-induced attaching and effacing lesionsInfect Immun20148241648165624491575
  • DahanSDalmassoGImbertVPeyronJFRampalPCzeruckaDSaccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cellsInfect Immun200371276677312540556
  • WuXVallanceBABoyerLSaccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factorsAm J Physiol Gastrointest Liver Physiol20082941G295G30618032474
  • ButsJPDekeyserNStilmantCDelemESmetsFSokalESaccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylationPediatr Res2006601242916690953
  • HoyBGeppertTBoehmMDistinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherinJ Biol Chem201228713101151012022337879
  • MumyKLChenXKellyCPMcCormickBASaccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling eventsAm J Physiol Gastrointest Liver Physiol20082943G599G60918032477
  • MartinsFSDalmassoGArantesRMInteraction of Saccharomyces boulardii with Salmonella enterica serovar typhimurium protects mice and modifies T84 cell response to the infectionPLoS One201051e892520111723
  • MartinsFSVieiraATElianSDInhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in miceMicrobes Infect201315427027923376166
  • TiagoFCMartinsFSSouzaELAdhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probioticsJ Med Microbiol201261Pt 91194120722580913
  • Pontier-BresRProdonFMunroPModification of Salmonella typhimurium motility by the probiotic yeast strain Saccharomyces boulardiiPLoS One201273e3379622442723
  • Pontier-BresRMunroPBoyerLSaccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tractPLoS One201498e10306925118595
  • SchmidtEKellySMvan der WalleCFTight junction modulation and biochemical characterisation of the zonula occludens toxin C-and N-terminiFEBS Lett2007581162974298017553496
  • CzeruckaDRampalPEffect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl− secretion in T84 cellsDig Dis Sci199944112359236810573387
  • CzeruckaDNanoJLBernasconiPRampalPResponse to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardiiGastroenterol Clin Biol1989134383387 French2544474
  • BrandãoRLCastroIMBambirraEAIntracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiaeAppl Environ Microbiol19986425645689464394
  • TafazoliFZengCQEstesMKMagnussonKESvenssonLNSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cellsJ Virol20017531540154611152526
  • BuccigrossiVLaudieroGRussoCChloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytesPLoS One201496e9983024918938
  • SwidsinskiALoening-BauckeVKirschSDoerffelYFunctional biostructure of colonic microbiota (Central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardiiGastroentérologie Clinique et Biologique201034Suppl 1S79S92 French20889010
  • BinZYa-ZhengXZhao-HuiDBoCLi-RongJVandenplasYThe efficacy of Saccharomyces boulardii CNCM I-745 in addition to standard Helicobacter pylori eradication treatment in childrenPediatr Gastroenterol Hepatol Nutr2015181172225866729
  • KabbaniTAPallavKDowdSEProspective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteersGut Microbes201781173227973989
  • JumpRLClostridium difficile infection in older adultsAging Health20139440341424955106
  • NusratAvon Eichel-StreiberCTurnerJRVerkadePMadaraJLParkosCAClostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteinsInfect Immun20016931329133611179295
  • HechtGPothoulakisCLaMontJTMadaraJLClostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayersJ Clin Invest1988825151615243141478
  • BeaugerieLFlahaultABarbutFStudy GroupAntibiotic-associated diarrhoea and Clostridium difficile in the communityAliment Pharmacol Ther200317790591212656693
  • MassotJSanchezOCouchyRAstoinJParodiALBacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamsterArzneimittelforschung19843477947976541916
  • ToothakerRDElmerGWPrevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardiiAntimicrob Agents Chemother19842645525566517545
  • CorthierGDubosFDucluzeauRPrevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardiiCan J Microbiol198632118948963815159
  • ElmerGWMcFarlandLVSuppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamstersAntimicrob Agents Chemother19873111291313566236
  • ButsJPBernasconiPVaermanJPDiveCStimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardiiDig Dis Sci19903522512562302983
  • CastagliuoloILaMontJTNikulassonSTPothoulakisCSaccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileumInfect Immun19966412522552328945570
  • CastagliuoloIRieglerMFValenickLLaMontJTPothoulakisCSaccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosaInfect Immun19996713023079864230
  • SougioultzisSSimeonidisSBhaskarKRSaccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expressionBiochem Biophys Res Commun20063431697616529714
  • HalpernMDDenningPWThe role of intestinal epithelial barrier function in the development of NECTissue Barriers201531–2e100070725927016
  • RodríguezJMMurphyKStantonCThe composition of the gut microbiota throughout life, with an emphasis on early lifeMicrob Ecol Health Dis2015262605025651996
  • Gomez de AgüeroMGanal-VonarburgSCFuhrerTThe maternal microbiota drives early postnatal innate immune developmentScience201635162791296130226989247
  • DigiulioDBRomeroRAmoganHPMicrobial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigationPLoS One200838e305618725970
  • FlassTTongSFrankDNIntestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosisPLoS One2015102e011696725658710
  • JiménezEFernándezLMarínMLIsolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean sectionCurr Microbiol200551427027416187156
  • AjslevTAAndersenCSGamborgMSørensenTIJessTChildhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibioticsInt J Obes (Lond)201135452252921386800
  • YassourMVatanenTSiljanderHXavierRJDIABIMMUNE Study GroupNatural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stabilitySci Transl Med20168343343ra81
  • JohnsonCCOwnbyDRThe infant gut bacterial microbiota and risk of pediatric asthma and allergic diseasesTransl Res2017179607027469270
  • BerdingKDonovanSMDiet can impact microbiota composition in children with autism spectrum disorderFrontiers in neuroscience201812
  • JakaitisBMDenningPWHuman breast milk and the gastrointestinal innate immune systemClin Perinatol201441242343524873841
  • WestCERenzHJenmalmMCThe gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapiesJournal of Allergy and Clinical Immunology201511135131325567038
  • SjögrenYMTomicicSLundbergAInfluence of early gut microbiota on the maturation of childhood mucosal and systemic immune responsesClin Exp Allergy200939121842185119735274
  • RoundJLMazmanianSKInducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProc Natl Acad Sci USA201010727122041220920566854
  • DemirelGErdeveOCelikIHDilmenUSaccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled studyActa Paediatrica201310212e560e56524028629
  • DrosteJHWieringaMHWeylerJJNelenVJVermeirePAVan BeverHPDoes the use of antibiotics in early childhood increase the risk of asthma and allergic disease?Clin Exp Allergy2000301115481553
  • OngM-SUmetsuDTMandlKDConsequences of antibiotics and infections in infancy: bugs, drugs, and wheezingAnn Allergy Asthma Immunol20141125441445.e124631182
  • BaileyLCForrestCBZhangPRichardsTMLivshitsADeRussoPAAssociation of antibiotics in infancy with early childhood obesityJAMA Pediatr2014168111063106925265089
  • CukrowskaBSowińskaABierłaJBCzarnowskaERybakAGrzybowska-ChlebowczykUIntestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac diseaseWorld J Gastroenterol201723427505751829204051
  • WestCERenzHJenmalmMCin-FLAME Microbiome Interest GroupThe gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapiesJ Allergy Clin Immunol20151351313 quiz 1425567038
  • BjörksténBSeppEJulgeKVoorTMikelsaarMAllergy development and the intestinal microflora during the first year of lifeJ Allergy Clin Immunol2001108451652011590374
  • HarbisonJERoth-SchulzeAJBarrySCGut microbiome dysbiosis and increased intestinal permeability in Australian children with islet autoimmunity and type 1 diabetesDiabetes201867Suppl 1230-OR2300
  • Leiva-GeaISánchez-AlcoholadoLMartín-TejedorBGut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: a case-control studyDiabetes Care201841112385239530224347
  • LiXAtkinsonMAThe role for gut permeability in the pathogenesis of type 1 diabetes–a solid or leaky concept?Pediatr Diabetes201516748549226269193
  • MaffeisCMartinaACorradiMAssociation between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetesDiabetes Metab Res Rev201632770070926891226
  • AbrahamssonTRJakobssonHEAnderssonAFBjörksténBEngstrandLJenmalmMCLow diversity of the gut microbiota in infants with atopic eczemaJ Allergy Clin Immunol20121292434440e1-e222153774
  • OzkanTBSahinEErdemirGBudakFEffect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune responseJ Int Med Res200735220121217542407
  • CaetanoJAParamésMTBaboMJImmunopharmacological effects of Saccharomyces boulardii in healthy human volunteersInt J Immunopharmacol1986832452593733298
  • DelzenneNMNeyrinckAMCaniPDGut microbiota and metabolic disorders: how prebiotic can work?Br J Nutr2013109Suppl 2S81S8523360884
  • LiuLSteinleJJToll-like receptor 4 regulates insulin signal transduction in retinal Müller cellsGrowth Factors201735623423829490521
  • SzaboGGut–Liver axis in alcoholic liver diseaseGastroenterology20151481303625447847
  • MieleLValenzaVLa TorreGIncreased intestinal permeability and tight junction alterations in nonalcoholic fatty liver diseaseHepatology20094961877188719291785
  • BaumgartDCSandbornWJInflammatory bowel disease: clinical aspects and established and evolving therapiesLancet200736995731641165717499606
  • CosnesJGower-RousseauCSeksikPCortotAEpidemiology and natural history of inflammatory bowel diseasesGastroenterology201114061785179421530745
  • RajcaSGrondinVLouisEAlterations in the intestinal micro-biome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn’s diseaseInflamm Bowel Dis201420697898624788220
  • ChangJLeongRWWasingerVCIpMYangMPhanTGImpaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healingGastroenterology20171533723731.e128601482
  • ZbarAPSimopoulosCKarayiannakisAJCadherins: an integral role in inflammatory bowel disease and mucosal restitutionJ Gastroenterol200439541342115175938
  • BourreilleACadiotGLe DreauGFLORABEST Study GroupSaccharomyces boulardii does not prevent relapse of Crohn’s diseaseClin Gastroenterol Hepatol201311898298723466709
  • Garcia VilelaEDe Lourdes De Abreu FerrariMOswaldo da Gama TorresHInfluence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn’s disease in remissionScand J Gastroenterol200843784284818584523
  • CanoniciASiretCPellegrinoESaccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptorPLoS One201163e1842721483797
  • CanoniciAPellegrinoESiretCSaccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation statePLoS One201279e4504723028753
  • LovellRMFordACGlobal prevalence of and risk factors for irritable bowel syndrome: a meta-analysisClin Gastroenterol Hepatol2012107712721.e422426087
  • MearinFBeLChangLBowel disordersGastroenterology2016150613931407
  • PicheTBarbaraGAubertPImpaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediatorsGut200958219620118824556
  • Bertiaux-VandaëleNYoumbaSBBelmonteLThe expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtypeAm J Gastroenterol2011106122165217322008894
  • AbbasZYakoobJJafriWCytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trialEur J Gastroenterol Hepatol201426663063924722560
  • JumpertzRLeDSTurnbaughPJEnergy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humansAm J Clin Nutr2011941586521543530
  • ZhangYJLiSGanRYZhouTXuDPLiHBImpacts of gut bacteria on human health and diseasesInt J Mol Sci20151647493751925849657
  • ZinöckerMLindsethIThe western diet–microbiomehost interaction and its role in metabolic diseaseNutrients2018103E36529562591
  • GenserLPoitouCÉB-LAlteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?Med Sci (Paris)201632546146927225918
  • KimKAGuWLeeIAJohEHKimDHHigh fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathwayPLoS One2012710e4771323091640
  • HamiltonMKBoudryGLemayDGRaybouldHEChanges in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependentAm J Physiol Gastrointest Liver Physiol201530810G840G85125747351
  • EverardAMatamorosSGeurtsLDelzenneNMCaniPDSaccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db miceMBio201453e010110101424917595
  • SchnablBBrennerDAInteractions between the intestinal microbiome and liver diseasesGastroenterology201414661513152424440671
  • ChangBSangLWangYTongJWangBThe role of FOXO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injuryInt J Mol Med201331356957623292333
  • KarahanNIşlerMKoyuAEffects of probiotics on methionine choline deficient diet-induced steatohepatitis in ratsTurk J Gastroenterol201223211012122706738
  • SchneiderSMGirard-PipauFFilippiJEffects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutritionWorld J Gastroenterol200511396165616916273644
  • FengYSunXYangHTeitelbaumDHDissociation of E-cadherin and beta-catenin in a mouse model of total parenteral nutrition: a mechanism for the loss of epithelial cell proliferation and villus atrophyJ Physiol2009587Pt 364165419064618
  • NazliAChanODobson-BelaireWNExposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocationPLoS Pathog201064e100085220386714
  • Villar-GarcíaJHernándezJJGüerri-FernándezREffect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trialJ Acquir Immune Defic Syndr201568325626325469528
  • Al-SadiRYeDBoivinMInterleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 genePLoS One201493e8534524662742
  • MutluEAKeshavarzianALosurdoJA compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjectsPLoS Pathog2014102e100382924586144
  • CapaldoCTNusratACytokine regulation of tight junctionsBiochim Biophys Acta178820094864871
  • Villar-GarcíaJGüerri-FernándezRMoyaAImpact of probi-otic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: a double-blind, randomised, placebo-controlled trialPLoS One2017124e017380228388647
  • BrevesGFaulKSchröderBHolstHCasparyWFSteinJApplication of the colon-simulation technique for studying the effects of Saccharomyces boulardii on basic parameters of porcine cecal microbial metabolism disturbed by clindamycinDigestion200061319320010773725